Carel du Marchie Sarvaas is Executive Director of HealthforAnimals, the global animal medicines association, representing the top 10 global animal health companies developing and manufacturing veterinary pharmaceuticals, vaccines, parasiticides and other products. He has been a senior government affairs and communications professional for 25 years. He joined HealthforAnimals in 2014 after holding the position of Director at EuropaBio. Prior to that, he worked at consultancies and think tanks in Brussels and Washington DC, advising clients active in the food, agriculture, chemicals, nanotech and biotech sectors. He is Dutch national, married, has four children and holds degrees from the University of Leiden and the Johns Hopkins University.

Edna Massay Kallon works in the Agriculture Global Practice of the World Bank and leads the Livestock Topic Team in a World Bank Group project titled Enabling the Business of Agriculture. She manages a team developing a series of indicators that identify and measure legal, regulatory and market issues impacting the enabling business environment for livestock input and service suppliers globally, including inputs such as livestock medicinal products. Edna joined the World Bank in 2012 and before that worked for the United Nations Food and Agriculture Organization in the Iraq country office. Edna is from Sierra Leone and holds a degree from Johns Hopkins Paul H. Nitze School of Advanced International Studies.

Education Graduated in 1996 with a Master of Biotechnology, from INSA, France and with a Diplomacy and International Relations Diploma, from CEDS Paris, in 2015 Work experience with MERIAL, since 1990 Work in Industrial operations for 10 years, as vaccines downstream process and Quality Control Manager Regulatory Affairs Director: starting to manage Asia countries, based in Singapore from 2001 till 2005. Then manage International region (Asia including China and Japan, Australia, Latin America, Canada). Since 2012 focusing on Regulatory Affairs to allow growth of emerging markets : Africa, Middle-East, Russia, CIS countries.

Prof. Dr Verma, B.Sc., B.V.Sc. & A.H., M.V.Sc., M.Sc. (Immunology, UK), M.V.M. (NZ), Ph.D. (IVRI), D.Sc. (Microbiol) has held post of Joint-Director, Centre for Animal Disease Research and Diagnosis, Joint Director (Research), National Dairy Research Institute, Karnal, Head, Division of Biological Standardization, Govt of India Analyst. Member of important committee of Drugs Controller General (India), Chairman, Indian Pharmacopeia, Vet. Expert Group. Expert in Joint Inspection of for drug license or GMP license, regulated import of veterinary vaccines, nominated as Expert by Govt of Madhya Pradesh, Punjab, Bihar, Uttar Pradesh and Institute of Animal Health & Veterinary Biologicals, Bangalore, for GMP of biological units.

After obtaining her Doctor of Veterinary Medicine degree from Tuskegee University, Dr. Walters held a variety of positions in academia and the public sector that support the One Health strategy. Currently, she is an international policy analyst with the US Food and Drug Administration where she develops and administers international policies and programs that protect human and animal health and safety through the regulation of animal drugs, feed additives, veterinary medical devices and other veterinary medical products.

Gilly studied Microbiology and Immunology in the 1960/70s in London. She began a career in R&D at the Lister Institute, followed by 2 years at Bedford Hospital. In 1976 she joined Hoechst Animal Health R&D developing vaccines then transferred into Regulatory Affairs in 1981. After 4 years at the German HQ of Hoechst she returned to the UK in 2000 to join Aquaculture Vaccines Ltd. In 2002 she became Director of Regulatory Affairs for Pfizer. Gilly has been chair of the NOAH’s Biologicals Committee and a member of the IFAH Biologicals Committee. She retired from Pfizer in 2010 and is now a consultant involved in harmonising registration requirements and setting up a Mutual Recognition Procedure in East Africa, funded by GALVmed.

He has joined JMAFF since 2001 working at NVAL as Research Officer, also as Associate Director for Veterinary Medicinal Product (VMP) Administration at JMAFF Head Quarter. Before joining JMAFF, he had teaching and research experiences in the area of biochemistry, physiology and microbiology at veterinary and bioscience universities. He is now managing a research team developing quality assurance methodology for cell-based medicine as well as approval process for VMPs with novel technology. He also serves as VICH Steering Committee member and OIE National Focal Point for Veterinary Products for years.

Erik De Ridder graduated as a Doctor in veterinary medicines from the University of Ghent in 1989, after obtaining a master’s degree in educational sciences. Following a short academic career, he joined Elanco, the Animal Health division of Eli Lilly and company, working in clinical research, scientific support and mainly regulatory affairs. He obtained a permanent appointment as a part-time professor at the Faculty of Pharmaceutical Sciences of the Catholic University of Leuven in Belgium where he still teaches. Erik has been a member of the Technical Regulatory Committee of the European Animal Health Association IFAH-Europe and is its current chair. He is active in several Health for Animals and IFAH Europe working parties and committees.

Atsushi Yamamoto has been working at National Veterinary Assay Laboratory(NVAL), Ministry of Agriculture, Forestry and Fisheries, Japan. NVAL is responsible for assuring the quality, efficacy and safety of veterinary medicinal products (VMPs) and veterinary medical devices (VMDs). NVAL’s main activities are planning and coordinating of inspections and tests, national assay, and distribution of national standard materials. He has experienced national assay of veterinary biological products and spot sampling test of VMPs. He is now responsible for reviewing application dossier forVMPs and VMDs.

Jean-Pierre Orand has been working as Director of the French Agency for Veterinary Medicinal Products (Anses-ANMV) since 2010. Anses-ANMV is an OIE (World Organization for Animal Health) collaborating centre for veterinary medicinal products. He has chaired the task force for implementation of legislation at HMA since 2010 and is a member of the Telematics Management Board.Dr Orand holds a degree in veterinary medicine.He worked in food safety, veterinary medicinal products, intern. trade and foreign affairs for the French ministry of agriculture for 19 years. He has negotiated several cooperation protocols, set up twinnings with 3rd countries and was the official delegate for France at the World Trade Organization for the SPS agreement.

Dr Enrique Argento is a veterinarian from the Buenos Aires State University. Secretary of CAMEVET since 2011. Representative of CAPROVE ( Argentine Chamber of Veterinary Products) at CAMEVET at CAMEVET for 17 years. Representative of CAPROVE in the Veterinary Products Comission of Mercosur. Partner and Technical Director of Instituto de Sanidad Ganadera a private company of veterinary products. Professor of inmunology at the University of Buenos Aires- Veterinary School and professor of Animal Health at the Catholic University of Argentina. Member of the Biologic Commission of PROSAIA ( Foundation for the, promotion, investigation and education of animal food health).

J. Kevin Rice, Ph.D., is a Master Reviewer with the US Food and Drug Administration, Center for Veterinary Medicine, Office of New Animal Drug Evaluation, in the Division of Manufacturing Technologies. His graduate studies were in the field of polymer chemistry, and his area of work within CVM is mainly sterile injectable drug products, with an emphasis on the container closure systems used in these products.

Presently Managing Director at Biovet PVT. Ltd, Bangalore;Veterinary graduate from Ranchi Vet. College, Masters form IVRI, Izatnagar PG from INRA, France. Worked from 1976 in BAIF, Pune, one of the biggest NGO in Asia. HRvet, Intervet, now MSD, Pune. He is also president of IAAVR and member in various committees in government of India, governing council member of national Institute of Animal Biotechnology, Government of India. He studied and travelled for FMD vaccine development, worked with WRL, UK, US, Netherlands France, and Switzerland. Developed new vaccines for blue tongue and John’s disease first in India.

Dr. Anna O’Brien is a veterinary medical officer with the Office of New Animal Drug Evaluation in the Center for Veterinary Medicine at the US Food and Drug Administration (FDA). Her expertise is in the pre-market approval of therapeutic veterinary products for food animals, focusing on antiparasitic and physiologic products.

Barbara Agate Borges Cordeiro is a Brazilian Veterinary Officer and has been working at the Ministry of Agriculture, Livestock and Food Supply since 2007. She is actually the Coordinator of Veterinary Products at the Department of Inspection for Livestock Inputs, responsible for the regulation, inspection and control of veterinary products in Brazil, including their registration. Before, she worked as the Technical Responsible for the Service of Inspection for Livestock Inputs at the Federal Superintendence of Agriculture, Livestock and Food Supply in the State of São Paulo and was also a member of the Biossecurity Comisssion for Laboratories that produce Biological Veterinary Products. Barbara Cordeiro lives in Brasilia-DF, Brazil.